Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders

Journal of Alzheimer's Disease

Volumn 17, Issue 4, 2009, Pages 863-873

  Meyne, Felix ^a   Gloeckner, Sara Friederike ^a   Ciesielczyk, Barbara ^a   Heinemann, Uta ^a   Krasnianski, Anna ^a   Meissner, Bettina ^a   Zerr, Inga ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Alzheimer's disease; Amyloid ; Cerebrospinal fluid; Creutzfeldt Jakob disease; Dementia; Dementia with Lewy bodies; Disease severity; Prion protein; Tau

Indexed keywords

PRION PROTEIN; PRION;

ADULT; AGE DETERMINATION; ALZHEIMER DISEASE; ARTICLE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID LEVEL; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; DISEASE DURATION; DISEASE SEVERITY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SEIZURE; SEX DIFFERENCE; AGE; AGED; CEREBROSPINAL FLUID; COMPARATIVE STUDY; GENERALIZED EPILEPSY; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRION; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN ISCHEMIA; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY, GENERALIZED; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MENINGITIS; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; PARKINSON DISEASE; PRIONS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 68949099356     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1110     Document Type: Article

References (38)

1. Schätzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB (1995) Prion protein gene variation among primates. J Mol Biol 245, 362-374.
2. Krakauer DC, Zanotto PM, Pagel M (1998) Prion's progress: patterns and rates of molecular evolution in relation to spongi-form disease. J Mol Evol 47, 133-145.
3. Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240.
4. Farquhar CF, Dornan J, Somerville RA, Tunstall AM, Hope J (1994) Effect of Sinc genotype, agent isolate and route of infection on the accumulation of protease-resistant PrP in non-central nervous system tissues during the development of murine scrapie. J Gen Virol 75, 495-504.
5. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95, 13363-13383.
6. Hill C (1990) Re: "The question of clustering of Creutzfeldt-Jakob disease" [letter; comment]. Am J Epidemiol 131, 378-379.
7. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM (2000) Normal prion protein has an activity like that of superoxide dismutase. Biochem J 345, 767.
8. Wong BS, Pan T, Liu T, Li R, Petersen RB, Jones IM, Gam-betti P, Brown DR, Sy MS (2000) Prion disease: A loss of antioxidant function? Biochem Biophys Res Commun 275, 249-252.
9. Wong BS, Pan T, Liu T, Li R, Gambetti P, Sy MS (2000) Differential contribution of susperoxide dismutase activity by prion protein in vivo. Biochem Biophys Res Commun 273, 136-139.
10. Kramer ML, Kratzin HD, Schmidt B, Romer A, Windl O, Lie-mann S, Hornemann S, Kretzschmar H (2001) Prion protein binds copper within the physiological concentration range. J Biol Chem 276, 16711-16719.
11. Bounhar Y, Zhang Y, Goodyer CG, LeBlanc AC (2001) Prion protein protects human neurons against Bax-mediated apop-tosis. J Biol Chem 276, 39145-39149.
12. Chen S, Mangé A, Dong L, Lehmann S, Schachner M (2003) Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal suvival. Mol Cell Neurosci 22, 227-233.
13. Chiarini LB, Freitas AR, Zanata SM, Berntani RR, Martins VR, Linden R (2002) Cellular prion protein transduces neuro-protective signals. EMBO J 13, 3317-3326.
14. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000) Signal transduction through prion protein. Science 289, 1925-1928.
15. Vassallo N, Herms J, Behrens C, Krebs B, Saeki K, Ondera T, Windl O,Kretzschmar HA(2005) Activation of phosphatidyli-nositol 3-kinase by cellular prion protein and its role in cell survival. Biochem Biophys Res Commun 332, 75-82.
16. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, Hooper NM (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci USA 104, 11062-11067.
17. Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105, 244-252.
18. McKhann G, Drachmann D, Folstein M, Katzmann R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease. Neurology 34, 934-944.
19. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113-1124.
20. International Statistical Classification of Diseases and Related Health Problems. 10th Revision, http://www.who.int/ classifications/apps/icd/ icd10online/.
21. McDonald WI, Compston A, EdanG,Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerois: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50, 121-127.
22. Zerr I, Bodemer M, Kaboth U, Kretzschmar H, Oellerich M, Armstrong VW (2004) Plasminogen activities and concentrations in patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett 371, 163-166.
23. Alpérovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I, Collins S, Kretzschmar H, van Duijn C, Will RG (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353, 1673-1674.
24. Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, FenoglioC,Galimberti G,Galbiati S,VirgilioR,Galimberti D, Scarpini E, Bresolin N, Comi GP (2006) Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study andameta-analysis. Neurobiol Aging 27, 770.e1-770.e5.
25. Berr C, Richard F, Dufouil C, Amant C, Alperovitch A, Amouyel P (1998) Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study. Neurology 51, 734-737.
26. Dermaut B, Croes EA, Rademakers R, Van den Broeck M, Cruts M, Hofman A, van Duijn CM, Van Broeckhoven C (2003) PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease. Ann Neurol 53, 409-412.
27. Voigtländer T, Kloppel S, Birner P, Jarius C, Flicker H, Verghese-Nikolakaki S, Sklaviadis T, Guentchev M, Budka H (2001) Marked increase of neuronal prion protein immunore-activity in Alzheimer's disease and human prion diseases. Acta Neuropathol (Berl) 101, 417-423.
28. Jiménez-Huete A, Lievens PM, Vidal R, Piccardo P, Ghetti B, Tagliavini F, Frangione B, Prelli F (1998) Endogenous prote-olytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153, 1561-1572.
29. Kovács GG, Zerbi P, Voigtlander T, Strohschneider M, Tra-battoni G, Hainfellner JA, Budka H (2002) The prion protein in human neurodegenerative disorders. Neurosci Lett 329, 269-272.
30. Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mizushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarabayashi T, Ishiguro K, Harigaya Y, Wakabayashi H, Okamoto K, Hirai S, Shoji M (1998) Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol 44, 17-26.
31. Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N (2007) Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci Lett 419, 18-22.
32. Wallin AK, Blennow K, Andreasen N, Minthon L (2006) CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival. Dement Geriatr Cogn Disord 21, 131-138.
33. Sunderland T, Wolozin B, Galasko D, Levy J, Dukoff R, Bahro M, Lasser R, Motter R, Lehtimaki T, Seubert P (1999) Longitudinal stability of CSF tau levels in Alzheimer patients. Biol Psychiatry 46, 750-755.
34. Gloeckner SF, Meyne F, Wagner F, Heinemann U, Krasni-anski A, Meissner B, Zerr I (2008) Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J Alzheimers Dis 14, 17-25.
35. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P,Kretzschmar HA(1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46, 224-233.
36. Pocchiari M, Poupolo M, Croes EA, Budka H, Gelpi E,Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, Brandel JP, Alperovitch A, Zerr I, Poser S, Kretzschmar H, Ladogana A, Rietvald I, Mitrova E, Martinez-Martin P, de Pedro-Cuesta J, Glatzel M, Aguzzi A, Cooper S, Mackenzie J, Van Duijn C, Will R (2004) Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 10, 2348-2359.
37. Politopoulou G, Seebach JD, Schmugge M, Schwarz HP, Aguzzi A (2000) Age-related expression of the cellular prion protein in human peripheral blood leukocytes. Haematologica 85, 580-587.
38. Williams WM, Stadtman ER, Moskovitz J (2004) Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma. Neuropathol Appl Neurobiol 30, 161-168.